DiFusion Announces New Patent

DiFusion ZFUZE Biomaterial

DiFusion Technologies announced issuance of US Patent No. 12,178,936 B2, Medical Implants and Methods of Manufacture. The new patent is encompasses four methods to manufacture ZFUZE, a proprietary therapeutic, anti-inflammatory, osseoconductive, load bearing biomaterial for orthopedic implants.

ZFUZE is reported to be the first FDA-cleared...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0